Sionna Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SION research report →
Companywww.sionnatx.com
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
- CEO
- Michael Cloonan
- IPO
- 2025
- Employees
- 41
- HQ
- Waltham, MA, US
Price Chart
Valuation
- Market Cap
- $1.78B
- P/E
- -20.74
- P/S
- 0.00
- P/B
- 6.16
- EV/EBITDA
- -19.51
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -27.31%
- ROIC
- -33.35%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-75,268,000 · -22.01%
- EPS
- $-1.88 · -34.29%
- Op Income
- $-88,982,000
- FCF YoY
- -26.24%
Performance & Tape
- 52W High
- $48.45
- 52W Low
- $12.42
- 50D MA
- $39.56
- 200D MA
- $35.47
- Beta
- 1.34
- Avg Volume
- 373.72K
Get TickerSpark's AI analysis on SION
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 7, 26 | Thompson Peter A. | sell | 48,546 |
| May 8, 26 | Thompson Peter A. | sell | 59,767 |
| May 11, 26 | Thompson Peter A. | sell | 184,639 |
| May 7, 26 | ORBIMED ADVISORS LLC | sell | 48,546 |
| May 8, 26 | ORBIMED ADVISORS LLC | sell | 59,767 |
| May 11, 26 | ORBIMED ADVISORS LLC | sell | 184,639 |
| Apr 17, 26 | Thompson Peter A. | sell | 52,397 |
| Apr 18, 26 | Thompson Peter A. | sell | 2,948 |
| Apr 17, 26 | ORBIMED ADVISORS LLC | sell | 52,397 |
| Apr 18, 26 | ORBIMED ADVISORS LLC | sell | 2,948 |
Our SION Coverage
We haven't published any research on SION yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SION Report →